M. Kraus & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.51M | Sell |
39,151
-97
| -0.2% | -$21.5K | 2.48% | 15 |
|
|
2025
Q4 | $8.97M | Hold |
39,248
| – | – | 2.5% | 15 |
|
|
2025
Q3 | $9.09M | Sell |
39,248
-675
| -2% | -$137K | 2.54% | 15 |
|
|
2025
Q2 | $7.41M | Buy |
39,923
+234
| +0.6% | +$43.5K | 2.18% | 20 |
|
|
2025
Q1 | $8.32M | Sell |
39,689
-825
| -2% | -$160K | 2.53% | 20 |
|
|
2024
Q4 | $7.2M | Buy |
40,514
+371
| +0.9% | +$68.2K | 2.16% | 21 |
|
|
2024
Q3 | $7.93M | Sell |
40,143
-1,175
| -3% | -$219K | 2.32% | 22 |
|
|
2024
Q2 | $7.09M | Sell |
41,318
-130
| -0.3% | -$21.5K | 2.17% | 21 |
|
|
2024
Q1 | $7.55M | Buy |
41,448
+1,165
| +3% | +$201K | 2.29% | 21 |
|
|
2023
Q4 | $6.24M | Buy |
40,283
+2,363
| +6% | +$345K | 2.03% | 22 |
|
|
2023
Q3 | $5.65M | Sell |
37,920
-705
| -2% | -$103K | 2.01% | 22 |
|
|
2023
Q2 | $5.2M | Sell |
38,625
-777
| -2% | -$114K | 1.75% | 25 |
|
|
2023
Q1 | $6.28M | Sell |
39,402
-118
| -0.3% | -$18K | 2.22% | 21 |
|
|
2022
Q4 | $6.39M | Sell |
39,520
-38
| -0.1% | -$5.83K | 2.36% | 19 |
|
|
2022
Q3 | $5.31M | Sell |
39,558
-10
| -0% | -$1.44K | 2.22% | 21 |
|
|
2022
Q2 | $6.06M | Sell |
39,568
-5
| -0% | -$764 | 2.34% | 19 |
|
|
2022
Q1 | $6.42M | Buy |
39,573
+695
| +2% | +$101K | 2.16% | 22 |
|
|
2021
Q4 | $5.26M | Sell |
38,878
-866
| -2% | -$102K | 1.68% | 24 |
|
|
2021
Q3 | $4.29M | Buy |
39,744
+2
| +0% | +$229 | 1.53% | 26 |
|
|
2021
Q2 | $4.48M | Sell |
39,742
-680
| -2% | -$76.6K | 1.61% | 26 |
|
|
2021
Q1 | $4.37M | Sell |
40,422
-538
| -1% | -$57.5K | 1.7% | 25 |
|
|
2020
Q4 | $4.39M | Sell |
40,960
-812
| -2% | -$78K | 1.83% | 25 |
|
|
2020
Q3 | $3.66M | Sell |
41,772
-162
| -0.4% | -$15.3K | 1.73% | 24 |
|
|
2020
Q2 | $4.12M | Sell |
41,934
-235
| -0.6% | -$20.7K | 2.13% | 23 |
|
|
2020
Q1 | $3.21M | Sell |
42,169
-1,318
| -3% | -$112K | 1.95% | 22 |
|
|
2019
Q4 | $3.85M | Sell |
43,487
-306
| -0.7% | -$25.4K | 1.92% | 24 |
|
|
2019
Q3 | $3.32M | Sell |
43,793
-2,484
| -5% | -$170K | 1.8% | 23 |
|
|
2019
Q2 | $3.37M | Sell |
46,277
-1,609
| -3% | -$126K | 1.87% | 23 |
|
|
2019
Q1 | $3.86M | Sell |
47,886
-1,571
| -3% | -$129K | 2.26% | 22 |
|
|
2018
Q4 | $4.56M | Sell |
49,457
-6,640
| -12% | -$584K | 3.01% | 18 |
|
|
2018
Q3 | $5.31M | Sell |
56,097
-1,348
| -2% | -$128K | 3.07% | 16 |
|
|
2018
Q2 | $5.32M | Sell |
57,445
-8,983
| -14% | -$877K | 3.34% | 13 |
|
|
2018
Q1 | $6.29M | Sell |
66,428
-790
| -1% | -$86.8K | 3.99% | 9 |
|
|
2017
Q4 | $6.5M | Sell |
67,218
-1,590
| -2% | -$150K | 3.94% | 8 |
|
|
2017
Q3 | $6.11M | Sell |
68,808
-409
| -0.6% | -$31.1K | 3.82% | 8 |
|
|
2017
Q2 | $5.02M | Buy |
69,217
+1,091
| +2% | +$73.3K | 3.17% | 14 |
|
|
2017
Q1 | $4.44M | Sell |
68,126
-354
| -0.5% | -$22.3K | 2.91% | 20 |
|
|
2016
Q4 | $4.29M | Buy |
68,480
+60
| +0.1% | +$3.66K | 2.93% | 18 |
|
|
2016
Q3 | $4.32M | Sell |
68,420
-2,415
| -3% | -$156K | 2.98% | 17 |
|
|
2016
Q2 | $4.38M | Sell |
70,835
-110
| -0.2% | -$6.7K | 3.13% | 16 |
|
|
2016
Q1 | $4.05M | Buy |
70,945
+1,015
| +1% | +$56.6K | 3.01% | 16 |
|
|
2015
Q4 | $4.14M | Sell |
69,930
-390
| -0.6% | -$22.5K | 3.11% | 13 |
|
|
2015
Q3 | $3.83M | Sell |
70,320
-675
| -1% | -$43.9K | 3.08% | 15 |
|
|
2015
Q2 | $4.77M | Sell |
70,995
-195
| -0.3% | -$12.7K | 3.46% | 6 |
|
|
2015
Q1 | $4.17M | Buy |
71,190
+2,510
| +4% | +$152K | 2.99% | 12 |
|
|
2014
Q4 | $4.49M | Buy |
68,680
+2,785
| +4% | +$176K | 3.27% | 11 |
|
|
2014
Q3 | $3.81M | Sell |
65,895
-380
| -0.6% | -$21.1K | 2.92% | 15 |
|
|
2014
Q2 | $3.74M | Buy |
66,275
+715
| +1% | +$37.5K | 2.84% | 16 |
|
|
2014
Q1 | $3.37M | Buy |
65,560
+1,125
| +2% | +$56.9K | 2.74% | 18 |
|
|
2013
Q4 | $3.4M | Buy |
+64,435
| New | +$3.17M | 2.77% | 18 |
|
Other funds holding ABBV
VCM
VPM
M. Kraus & Co's ABBV Position: Q1 2026 in Review
M. Kraus & Co reduced its AbbVie (ABBV) stake by 0.25% in Q1 2026, selling an estimated $21.5K and leaving 39,151 shares worth $8.51M. The position accounts for 2.48% of the portfolio, ranked #15.
M. Kraus & Co first reported a position in ABBV in Q4 2013 and has held it in 50 quarters since. The position peaked at $9.09M in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- M. Kraus & Co held 39,151 shares of AbbVie worth $8.51M as of Q1 2026.
- M. Kraus & Co sold 97 AbbVie shares in Q1 2026, an estimated $21.5K.
- AbbVie made up 2.48% of M. Kraus & Co's portfolio in Q1 2026, its #15 holding.
- M. Kraus & Co first reported a position in AbbVie in Q4 2013 and has held it in 50 quarters since.
- M. Kraus & Co's AbbVie position peaked at $9.09M in Q3 2025.
- 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on M. Kraus & Co's 13F filing for Q1 2026, filed 14 Apr 2026.